Cargando…

Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity

BACKGROUND: Anandamide (AEA) and 2-arachidonoylglycerol (2-AG) play a pivotal role in stimulating motivational behavior toward food and energy metabolism. Aberrant functioning of the endocannabinoid system has been observed in extreme weight conditions (EWCs), suggesting it may influence pathophysio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baenas, Isabel, Miranda-Olivos, Romina, Granero, Roser, Solé-Morata, Neus, Sánchez, Isabel, Pastor, Antoni, del Pino-Gutiérrez, Amparo, Codina, Ester, Tinahones, Francisco J., Fernández-Formoso, José A., Vilarrasa, Núria, Guerrero-Pérez, Fernando, Lopez-Urdiales, Rafael, Virgili, Núria, Soriano-Mas, Carles, Jiménez-Murcia, Susana, de la Torre, Rafael, Fernández-Aranda, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305007/ https://www.ncbi.nlm.nih.gov/pubmed/37254556 http://dx.doi.org/10.1192/j.eurpsy.2023.2411

Ejemplares similares

The neural correlates of delay discounting in obesity and binge eating disorder
por: Miranda-Olivos, Romina, et al.
Publicado: (2021)

A multimodal MRI study of the neural mechanisms of emotion regulation impairment in women with obesity
por: Steward, Trevor, et al.
Publicado: (2019)

Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans
por: Fagundo, Ana B., et al.
Publicado: (2013)

Underlying Mechanisms Involved in Gambling Disorder Severity: A Pathway Analysis Considering Genetic, Psychosocial, and Clinical Variables
por: Solé-Morata, Neus, et al.
Publicado: (2023)

The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation
por: Smith, Marie, et al.
Publicado: (2015)

Endocannabinoids, Anandamide and 2-Arachidonoylglycerol, as Prognostic Markers of Sepsis Outcome and Complications
por: Šahinović, Ines, et al.
Publicado: (2023)

Peripheral endocannabinoids in eating disorders and obesity and its relationship with clinical and anthropometric variables
por: Baenas-Soto, I., et al.
Publicado: (2021)

The role of neurotrophin genes involved in the vulnerability to gambling disorder
por: Solé-Morata, Neus, et al.
Publicado: (2022)

What Difference Does it Make? Risk-Taking Behavior in Obesity after a Loss is Associated with Decreased Ventromedial Prefrontal Cortex Activity
por: Steward, Trevor, et al.
Publicado: (2019)

Neuropsychological Learning Deficits as Predictors of Treatment Outcome in Patients with Eating Disorders
por: Lucas, Ignacio, et al.
Publicado: (2021)

Cognitive flexibility and DSM-5 severity criteria for eating disorders: assessing drive for thinness and duration of illness as alternative severity variables
por: Mora-Maltas, Bernat, et al.
Publicado: (2023)

A Role for Peripheral Anandamide and 2-Arachidonoylglycerol in Short-Term Food Intake and Orexigenic Hypothalamic Responses in a Species with Continuous Nutrient Delivery
por: van Ackern, Isabel, et al.
Publicado: (2021)

Emotional regulation in eating disorders and gambling disorder: A transdiagnostic approach
por: Munguía, Lucero, et al.
Publicado: (2021)

Are Signals Regulating Energy Homeostasis Related to Neuropsychological and Clinical Features of Gambling Disorder? A Case–Control Study
por: Etxandi, Mikel, et al.
Publicado: (2022)

Does ADHD Symptomatology Influence Treatment Outcome and Dropout Risk in Eating Disorders? A longitudinal Study
por: Testa, Giulia, et al.
Publicado: (2020)

Emotion regulation as a transdiagnostic factor in eating disorders and gambling disorder: Treatment outcome implications
por: Vintró-Alcaraz, Cristina, et al.
Publicado: (2022)

A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women
por: Pastor, Antoni, et al.
Publicado: (2016)

Food addiction in anorexia nervosa: Implications for the understanding of crossover diagnosis
por: Sanchez, Isabel, et al.
Publicado: (2022)

Lifetime Weight Course as a Phenotypic Marker of Severity and Therapeutic Response in Patients with Eating Disorders
por: Agüera, Zaida, et al.
Publicado: (2021)

Food addiction and lifetime alcohol and illicit drugs use in specific eating disorders
por: Miranda-Olivos, Romina, et al.
Publicado: (2022)

Treatment outcome of patients with comorbid type 1 diabetes and eating disorders
por: Custal, Nuria, et al.
Publicado: (2014)

The Role of Food Addiction and Lifetime Substance Use on Eating Disorder Treatment Outcomes
por: Miranda-Olivos, Romina, et al.
Publicado: (2023)

Latent Classes for the Treatment Outcomes in Women with Gambling Disorder and Buying/Shopping Disorder
por: Granero, Roser, et al.
Publicado: (2022)

Are Neurotrophin Genes Involved in the Pathophysiology of Gambling Disorder?
por: Baenas, I., et al.
Publicado: (2022)

Lifetime Obesity in Patients with Eating Disorders: Increasing Prevalence, Clinical and Personality Correlates
por: Villarejo, Cynthia, et al.
Publicado: (2012)

Impulsivity, Emotional Dysregulation and Executive Function Deficits Could Be Associated with Alcohol and Drug Abuse in Eating Disorders
por: Lozano-Madrid, María, et al.
Publicado: (2020)

Eating Disorders and Addictive Behaviors: Implications for Human Health
por: Fernández-Aranda, Fernando, et al.
Publicado: (2023)

Editorial: Neurological, psychological and endocrine markers of eating disorders and obesity
por: Fernández-Aranda, Fernando, et al.
Publicado: (2023)

Role of adipose tissue GLP-1R expression in metabolic improvement after bariatric surgery in patients with type 2 diabetes
por: Ejarque, Miriam, et al.
Publicado: (2019)

Long-Term Effects in Bone Mineral Density after Different Bariatric Procedures in Patients with Type 2 Diabetes: Outcomes of a Randomized Clinical Trial
por: Guerrero-Pérez, Fernando, et al.
Publicado: (2020)

Non-suicidal Self-Injury in Eating Disordered Patients: Associations with Heart Rate Variability and State-Trait Anxiety
por: Giner-Bartolome, Cristina, et al.
Publicado: (2017)

Impact of Impulsivity and Therapy Response in Eating Disorders from a Neurophysiological, Personality and Cognitive Perspective
por: Testa, Giulia, et al.
Publicado: (2022)

Delay Discounting in Gambling Disorder: Implications in Treatment Outcome
por: Mena-Moreno, Teresa, et al.
Publicado: (2022)

Longitudinal Changes in Gambling, Buying and Materialism in Adolescents: A Population-Based Study
por: Estévez, Ana, et al.
Publicado: (2021)

Editorial: New advancement in network and path-analysis approaches for the study of disorders within the impulse-compulsive spectrum disorders
por: Granero, Roser, et al.
Publicado: (2022)

Does Confinement Affect Treatment Dropout Rates in Patients With Gambling Disorder? A Nine-Month Observational Study
por: Baenas, Isabel, et al.
Publicado: (2021)

Food Addiction in Eating Disorders and Obesity: Analysis of Clusters and Implications for Treatment
por: Jiménez-Murcia, Susana, et al.
Publicado: (2019)

A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass
por: Hernández-Montoliu, Laura, et al.
Publicado: (2023)

Internet gaming disorder and online gambling disorder: Clinical and personality correlates
por: Mallorquí-Bagué, Nuria, et al.
Publicado: (2017)

Role of FAAH-Like Anandamide Transporter in Anandamide Inactivation
por: Leung, KwanNok, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5tj28q54pamsgs5uqsdap8rq1t